Who Enrolled in a Randomized Controlled Trial of Quitline Support? Comparison of Participants Versus Nonparticipants

被引:4
|
作者
Tzelepis, Flora [1 ,2 ]
Paul, Christine L. [1 ,2 ]
Walsh, Raoul A. [2 ,3 ]
Knight, Jenny [1 ,2 ,4 ,5 ]
Wiggers, John [1 ,2 ,4 ,5 ]
机构
[1] Univ Newcastle, Prior Res Ctr Hlth Behav, Callaghan, NSW 2308, Australia
[2] Hunter Med Res Inst, Callaghan, NSW 2308, Australia
[3] Univ Newcastle, Ctr Hlth Res & Psychooncol, Canc Council New South Wales, Callaghan, NSW 2308, Australia
[4] Univ Newcastle, Hunter New England Populat Hlth, Hunter New England Local Hlth Dist, Wallsend, NSW, Australia
[5] Hunter Med Res Inst, Wallsend, NSW, Australia
基金
澳大利亚研究理事会;
关键词
SMOKING-CESSATION TREATMENTS; TOBACCO CESSATION; TELEPHONE; RECRUITMENT; PREDICTORS;
D O I
10.1093/ntr/ntt114
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Understanding the characteristics of smokers who enroll in a trial of quitline support and those who decline could guide recruitment approaches and service delivery to better engage smokers and increase successful quitting. However, it is unknown whether factors such as smokers' perceived effectiveness of using quitting aids or self-exempting beliefs are associated with quitline uptake. We compared the sociodemographic characteristics, smoking behaviours, perceived effectiveness of using quitting aids, and self-exempting beliefs of participants and nonparticipants who were actively telephoned and offered quitline support as part of a randomized controlled trial. Methods: Overall, 48,014 telephone numbers were randomly selected from the electronic telephone directory and contacted. A total of 3,008 eligible smokers were identified and invited to participate in a trial of quitline support. Consenting trial participants (n = 1,562) and nonparticipants (n = 500) completed a baseline interview. Results: Multivariate analysis showed that the following factors were associated with trial participation: consumption of 21 or more cigarettes per day (odds ratio [OR] = 1.45 [1.07-1.99]), readiness to quit within 30 days (OR = 4.45 [3.20-6.19]) or 6 months (OR = 3.22 [2.46-4.23]), perceiving that calling the quitline was definitely (OR = 2.34 [1.62-3.39]) or partly effective (OR = 2.15 [1.63-2.83]), believing that using self-help materials was partly effective (OR = 1.50 [1.16-1.94]), thinking that nicotine replacement therapy was partly effective (OR = 1.38 [1.04-1.84]), perceiving that using willpower alone was partly (OR = 1.99 [1.48-2.67]) or not effective (OR = 2.60 [1.95-3.46]), and not holding a self-exempting belief (OR = 1.45 [1.11-1.89]). Conclusions: Increasing smokers' utilization of quitlines is likely to require changing their perceptions of the effectiveness of quitting strategies compared with using willpower alone and addressing self-exempting beliefs.
引用
收藏
页码:2107 / 2113
页数:7
相关论文
共 50 条
  • [1] Telephone Recruitment into a Randomized Controlled Trial of Quitline Support
    Tzelepis, Flora
    Paul, Christine L.
    Walsh, Raoul A.
    Wiggers, John
    Knight, Jenny
    Lecathelinais, Christophe
    Daly, Justine
    Neil, Amanda
    Girgis, Afaf
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2009, 37 (04) : 324 - 329
  • [2] Support-Person Promotion of a Smoking Quitline A Randomized Controlled Trial
    Patten, Christi A.
    Smith, Christina M.
    Brockman, Tabetha A.
    Decker, Paul A.
    Hughes, Christine A.
    Nadeau, Ashley M.
    Sinicrope, Pamela S.
    Offord, Kenneth P.
    Lichtenstein, Edward
    Zhu, Shu-Hong
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2011, 41 (01) : 17 - 23
  • [3] Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study
    Sesso, HD
    Gaziano, JM
    VanDenburgh, M
    Hennekens, CH
    Glynn, RJ
    Buring, JE
    CONTROLLED CLINICAL TRIALS, 2002, 23 (06): : 686 - 702
  • [4] COMPARISON OF CHARACTERISTICS AND OUTCOMES OF SAPHENOUS VEIN GRAFT PATIENTS WHO WERE VERSUS THOSE WHO WERE NOT ENROLLED IN THE STENTING OF SAPHENOUS VEIN GRAFTS RANDOMIZED CONTROLLED TRIAL
    Michael, Tesfaldet T.
    Badhey, Neeraj
    Banerjee, Subhash
    Brilakis, Emmanouil
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1691 - E1691
  • [5] A Comparison Of Insulin Resistance In Patients Enrolled In A Randomized Controlled Trial Of Early Mobilization
    Giovanni, S.
    Patel, B. K.
    Wolfe, K. S.
    Pohlman, A. S.
    Hall, J. B.
    Kress, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [6] Characteristics of Participants Enrolled onto a Randomized Controlled Trial of Palliative Care for Patients on Phase I Studies
    Ferrell, Betty R.
    Paterson, Carly L.
    Hughes, Mark T.
    Chung, Vincent
    Koczywas, Marianna
    Smith, Thomas J.
    JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (12) : 1338 - 1344
  • [7] Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: A population-based comparison
    Jha, P
    Deboer, D
    Sykora, K
    Naylor, CD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (06) : 1335 - 1342
  • [8] MOBILE PHONES SUPPORT ADHERENCE AND RETENTION OF INDIGENOUS PARTICIPANTS IN A RANDOMIZED CONTROLLED TRIAL
    Mccallum, G.
    Versteegh, L.
    Morris, P.
    Mckay, C.
    Jacobsen, N.
    White, A.
    D'Antoine, H.
    Chang, A.
    RESPIROLOGY, 2014, 19 : 123 - 123
  • [9] A comparison of men treated for prostate cancer who enrolled in a randomized controlled trial compared with those who did not: data from the ENGAGE study
    Beharry, B. K.
    Craike, M.
    Courneya, K.
    Bolton, D.
    Sengupta, S.
    Livingston, P. M.
    BJU INTERNATIONAL, 2014, 113 : 43 - 43
  • [10] A COMPARISON OF MEN TREATED FOR PROSTATE CANCER WHO ENROLLED IN A RANDOMIZED CONTROLLED TRIAL COMPARED WITH THOSE WHO DID NOT: DATA FROM THE ENGAGE STUDY
    Sengupta, S.
    Beharry, B. K.
    Craike, M.
    Courneya, K.
    Bolton, D.
    Livingston, T.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 41 - 41